You are here: Industry Insights > COVID-19

News List

Kintor Pharma Announces First Patient Dosing in China in Phase III Clinical Trial of Proxalutamide for the Treatment of COVID-19 Outpatients prnasia
February 14, 2022
Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics...
Pluslife Biotech - A Greater Bay Area Company Launches First Handheld Covid-19 Nucleic Acid Test prnasia
February 14, 2022
Recently, Pluslife Biotech, an enterprise based in the Greater Bay Area, launched the first handheld Covid-19 Nucleic Acid Test to help with epidemic prevention and control.
Novartis seeks FDA EUA for Covid-19 antiviral candidate ensovibep Pharmaceutical-Technology
February 14, 2022
Molecular Partners has reported that its partner Novartis sought emergency use authorization (EUA) for the antiviral candidate, ensovibep, from the US Food and Drug Administration (FDA) to treat Covid-19.
First study to show waning effectiveness of 3rd dose of mRNA vaccines WorldPharmaNews
February 14, 2022
A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC) is the first to show that immunity against severe COVID-19 disease begins to wane 4 months after receipt of the third dose of an mRNA vaccine (Pfizer or Moderna).
Lilly's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19 WorldPharmaNews
February 14, 2022
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates neutralization against the Omicron variant, Eli Lilly and Company (NYSE: LLY) announced today.
Decision on third dose of COVID-19 vaccine for all adults will be based on scientific need: Government ExpressPharma
February 14, 2022
Responding to a question at a weekly press conference, Dr V K Paul, Member (health), NITI Aayog, said all decisions on precaution doses are taken first and foremost based on the need.
Vaccine Effectiveness Up After Three COVID-19 Vaccine Doses drugs.com
February 14, 2022
COVID-19 vaccine effectiveness (VE) is increased after three doses but wanes with time since vaccination after receipt of two or three...
Lilly's Bebtelovimab Receives EUA to Treat COVID-19 contractpharma
February 14, 2022
bebtelovimab is an antibody that demonstrates neutralization against the Omicron variant.
Lilly will supply up to 600,000 doses of bebtelovimab to U.S. government in ongoing effort to provide COVID-19 treatment options FirstWordPharma
February 11, 2022
Eli Lilly and Company (NYSE: LLY) today announced an agreement with the U.S. government to supply up to 600,000 doses of investigational drug bebtelovimab for at least $720 million.
Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil prnasia
February 11, 2022
Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostic company, today announced that it has signed a supply deal with the Ministry of Health of Brazil to deliver four million COVID-19 tests.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page